Page last updated: 2024-10-16

acetic acid and Liver Neoplasms

acetic acid has been researched along with Liver Neoplasms in 72 studies

Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)
acetic acid : A simple monocarboxylic acid containing two carbons.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"The purpose of this prospective study was to compare the efficacy of percutaneous acetic acid (PAAI) to that of radiofrequency ablation (RFA) in the treatment of small (≤5cm) hepatocellular carcinoma (HCC) using a randomized trial."9.34Acetic acid versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A randomized controlled trial. ( Acharya, SK; Gamanagatti, SR; Gulati, MS; Paul, SB; Shalimar, S; Sreenivas, V, 2020)
"To determine the feasibility and the long-term results of the acetic acid percutaneous injection under CT fluoroscopy guidance in a series of cirrhotic patients with small hepatocellular carcinoma in a single French center."9.11Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005)
"The aim of this study was to compare the outcomes of radiofrequency thermal ablation (RFTA), percutaneous ethanol injection (PEI), and percutaneous acetic acid injection (PAI) in the treatment of hepatocellular carcinoma (HCC)."9.11Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. ( Chen, YC; Hsu, CW; Lin, CC; Lin, CJ; Lin, SM, 2005)
"Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective loco-regional therapies for hepatocellular carcinoma (HCC)."9.11Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey. ( Chang, FY; Chiang, JH; Huang, YH; Huo, T; Lee, PC; Lee, SD; Wu, JC, 2004)
"Ultrasound-guided percutaneous ethanol injection (PEI) and percutaneous acetic acid injection (PAI) are effective in the treatment of hepatocellular carcinoma (HCC)."9.10Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2003)
"Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective treatments for hepatocellular carcinoma (HCC)."9.10Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. ( Chang, FY; Chiang, JH; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2003)
"To assess the efficacy of ultrasound-guided percutaneous acetic acid (15%, 20%, 30%, 40%, and 50% in concentration) injection for a large nodular hepatocellular carcinoma (HCC), percutaneous acetic acid injection was performed using 15% to 50% acetic acid in 28 patients who had one single nodular HCC larger than 3 cm or one main tumor with fewer than two HCCs smaller than 3 cm during the past 7."9.08Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1996)
"To assess the efficacy of ultrasound (US)-guided percutaneous acetic acid (in concentrations of 15%, 20%, 30%, 40%, and 50%) injection for small hepatocellular carcinomas (HCCs) for long-term prognosis, percutaneous acetic acid injection using 15% to 50% acetic acid was performed in 91 patients with one to four HCCs smaller than 3 cm during the past 6."9.08Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. ( Fujiwara, K; Ito, S; Nomura, F; Ohnishi, K, 1996)
"To assess whether ultrasound-guided percutaneous acetic acid injection is superior to percutaneous ethanol injection in the treatment of small hepatocellular carcinoma (HCC), 60 patients with one to four HCCs smaller than 3 cm were entered onto a randomized controlled trial."9.08Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1998)
"To assess whether ultrasound (US)-guided percutaneous acetic acid injection is more effective than percutaneous ethanol injection in the treatment of small hepatocellular carcinoma (HCC)."9.08Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. ( Ohnishi, K, 1998)
"To assess the efficacy of ultrasound-guided percutaneous acetic acid injection (PAI) in the treatment of hepatocellular carcinoma (HCC)."9.07Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. ( Fujiwara, K; Ito, S; Ohnishi, K; Ohyama, N, 1994)
"3-O-EZ and ingenol can relieve hepatic and gastrointestinal injuries, reduce ascites volumes, enhance the H22 cells apoptosis, ameliorate abnormal pro-inflammatory cytokines and RAAS levels, and down-regulate the expression of AQP8, AQP2, V2R."8.02The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC. ( Chen, PD; Ju, YH; Tang, YP; Wang, K; Wu, JH; Yao, WF; Zhang, L; Zhang, M; Zhang, Q; Zhang, Y, 2021)
"To evaluate the long-term outcome of CT-guided single high-dose percutaneous acetic acid injection (PAI) for the treatment of small hepatocellular carcinoma (SHCC)."7.78CT-guided single high-dose percutaneous acetic acid injection for small hepatocellular carcinoma: a long-term follow-up study. ( Liu, F; Liu, J; Ma, H, 2012)
"The long-term outcome of percutaneous acetic acid injection (PAI) and percutaneous ethanol injection (PEI) for treating small hepatocellular carcinoma (HCC) remains unclear."7.74Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study. ( Chan, HH; Chen, TA; Chen, WC; Cheng, JS; Hsu, PI; Lai, KH; Li, WL; Liang, HL; Lin, CK; Lin, CP; Lo, GH; Tsai, WL; Yu, HC, 2008)
"Ultrasound-guided percutaneous acetic acid injection (PAI) therapy is effective for hepatocellular carcinoma (HCC)."7.73Fever and infectious complications after percutaneous acetic acid injection therapy for hepatocellular carcinoma: incidence and risk factor analysis. ( Chang, FY; Huang, HC; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2006)
"The purpose of our study is to evaluate the distribution of acetic acid mixed with iodinated contrast agent during percutaneous acetic acid injection on CT fluoroscopy for hepatocellular carcinoma."7.72Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003)
"Monitoring acetic acid distribution on CT fluoroscopy can detect extratumoral diffusion and may optimize the distribution of acetic acid in hepatocellular carcinoma."7.72Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003)
"Ultrasound (US)-guided percutaneous acetic acid injection therapy (PAIT) is effective for patients with hepatocellular carcinoma (HCC)."7.72Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2004)
"To evaluate the safety and efficacy of single high-dose percutaneous acetic acid injection (PAI) for treatment of small (<3-cm-diameter) hepatocellular carcinoma (HCC)."7.70Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. ( Chen, CK; Cheng, JS; Lai, KH; Lai, PH; Liang, HL; Lo, GH; Pan, HB; Yang, CF, 2000)
"Percutaneous acetic acid injection is superior to segmental transcatheter arterial embolization in the treatment of hypervascular small hepatocellular carcinoma."7.69Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996)
"To compare the efficacy of ultrasound-guided percutaneous acetic acid injection and segmental transcatheter arterial embolization for hypervascular small hepatocellular carcinoma."7.69Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996)
"The prognosis of 40 patients with one to three angiographically hypervascular hepatocellular carcinoma smaller than 3 cm in diameter treated with either percutaneous acetic acid injection (25 patients) or transcatheter arterial embolization (15 patients) during the past 4."7.69Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996)
"One hundred and two patients with hepatocellular carcinoma were evaluated for treatment between 1999 and 2000."6.71Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005)
"The 1-, 2- and 3-year recurrence rate from the original main tumor was 0%, 20%, and 20%, respectively, in patients treated with percutaneous acetic acid injection alone and 12%, 24%, and 24% in patients treated with percutaneous acetic acid injection after transcatheter arterial embolization (P = NS)."6.68Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1996)
"The H22 mouse hepatoma ascites model was replicated, and were given 3-O-EZ and ingenol seven days (110."5.62The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC. ( Chen, PD; Ju, YH; Tang, YP; Wang, K; Wu, JH; Yao, WF; Zhang, L; Zhang, M; Zhang, Q; Zhang, Y, 2021)
"Despite the increasing incidence of hepatocellular carcinoma (HCC) worldwide, current pharmacological treatments are still unsatisfactory."5.62Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth. ( Altomare, A; Cavalluzzi, MM; Gnocchi, D; Lentini, G; Mangiatordi, GF; Mazzocca, A; Rizzi, R; Sabbà, C; Spennacchio, M; Tortorella, C, 2021)
"The purpose of this prospective study was to compare the efficacy of percutaneous acetic acid (PAAI) to that of radiofrequency ablation (RFA) in the treatment of small (≤5cm) hepatocellular carcinoma (HCC) using a randomized trial."5.34Acetic acid versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A randomized controlled trial. ( Acharya, SK; Gamanagatti, SR; Gulati, MS; Paul, SB; Shalimar, S; Sreenivas, V, 2020)
"Single high-dose PAI is safe and effective for treatment of small HCC."5.31Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. ( Chen, CK; Cheng, JS; Lai, KH; Lai, PH; Liang, HL; Lo, GH; Pan, HB; Yang, CF, 2000)
"Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective locoregional therapies for hepatocellular carcinoma (HCC)."5.11Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2004)
"Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective loco-regional therapies for hepatocellular carcinoma (HCC)."5.11Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey. ( Chang, FY; Chiang, JH; Huang, YH; Huo, T; Lee, PC; Lee, SD; Wu, JC, 2004)
"The aim of this study was to compare the outcomes of radiofrequency thermal ablation (RFTA), percutaneous ethanol injection (PEI), and percutaneous acetic acid injection (PAI) in the treatment of hepatocellular carcinoma (HCC)."5.11Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. ( Chen, YC; Hsu, CW; Lin, CC; Lin, CJ; Lin, SM, 2005)
"To determine the feasibility and the long-term results of the acetic acid percutaneous injection under CT fluoroscopy guidance in a series of cirrhotic patients with small hepatocellular carcinoma in a single French center."5.11Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005)
"Ultrasound-guided percutaneous ethanol injection (PEI) and percutaneous acetic acid injection (PAI) are effective in the treatment of hepatocellular carcinoma (HCC)."5.10Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2003)
"Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective treatments for hepatocellular carcinoma (HCC)."5.10Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. ( Chang, FY; Chiang, JH; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2003)
"To assess the efficacy of ultrasound (US)-guided percutaneous acetic acid (in concentrations of 15%, 20%, 30%, 40%, and 50%) injection for small hepatocellular carcinomas (HCCs) for long-term prognosis, percutaneous acetic acid injection using 15% to 50% acetic acid was performed in 91 patients with one to four HCCs smaller than 3 cm during the past 6."5.08Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. ( Fujiwara, K; Ito, S; Nomura, F; Ohnishi, K, 1996)
"To assess whether ultrasound-guided percutaneous acetic acid injection is superior to percutaneous ethanol injection in the treatment of small hepatocellular carcinoma (HCC), 60 patients with one to four HCCs smaller than 3 cm were entered onto a randomized controlled trial."5.08Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1998)
"To assess the efficacy of ultrasound-guided percutaneous acetic acid (15%, 20%, 30%, 40%, and 50% in concentration) injection for a large nodular hepatocellular carcinoma (HCC), percutaneous acetic acid injection was performed using 15% to 50% acetic acid in 28 patients who had one single nodular HCC larger than 3 cm or one main tumor with fewer than two HCCs smaller than 3 cm during the past 7."5.08Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1996)
"To assess whether ultrasound (US)-guided percutaneous acetic acid injection is more effective than percutaneous ethanol injection in the treatment of small hepatocellular carcinoma (HCC)."5.08Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. ( Ohnishi, K, 1998)
"To assess the efficacy of ultrasound-guided percutaneous acetic acid injection (PAI) in the treatment of hepatocellular carcinoma (HCC)."5.07Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. ( Fujiwara, K; Ito, S; Ohnishi, K; Ohyama, N, 1994)
" Keywords were Hepatocellular carcinoma, liver metastases, percutaneous ethanol injection, cryotherapy, microwave coagulation therapy, radiofrequency ablation, interstitial laser photocoagulation, focused high-intensity ultrasound, hot saline injection, electrolysis and acetic acid injection."4.82The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. ( Aylott, C; Berry, DP; Garcea, G; Lloyd, TD; Maddern, G, 2003)
"3-O-EZ and ingenol can relieve hepatic and gastrointestinal injuries, reduce ascites volumes, enhance the H22 cells apoptosis, ameliorate abnormal pro-inflammatory cytokines and RAAS levels, and down-regulate the expression of AQP8, AQP2, V2R."4.02The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC. ( Chen, PD; Ju, YH; Tang, YP; Wang, K; Wu, JH; Yao, WF; Zhang, L; Zhang, M; Zhang, Q; Zhang, Y, 2021)
"To evaluate the long-term outcome of CT-guided single high-dose percutaneous acetic acid injection (PAI) for the treatment of small hepatocellular carcinoma (SHCC)."3.78CT-guided single high-dose percutaneous acetic acid injection for small hepatocellular carcinoma: a long-term follow-up study. ( Liu, F; Liu, J; Ma, H, 2012)
"We investigated the effect of acetic acid (AcOH) on the prevention of obesity in high-fat-fed mice."3.75Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation. ( Fushimi, T; Kaga, T; Kishi, M; Kondo, T, 2009)
"The long-term outcome of percutaneous acetic acid injection (PAI) and percutaneous ethanol injection (PEI) for treating small hepatocellular carcinoma (HCC) remains unclear."3.74Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study. ( Chan, HH; Chen, TA; Chen, WC; Cheng, JS; Hsu, PI; Lai, KH; Li, WL; Liang, HL; Lin, CK; Lin, CP; Lo, GH; Tsai, WL; Yu, HC, 2008)
"Ultrasound-guided percutaneous acetic acid injection (PAI) therapy is effective for hepatocellular carcinoma (HCC)."3.73Fever and infectious complications after percutaneous acetic acid injection therapy for hepatocellular carcinoma: incidence and risk factor analysis. ( Chang, FY; Huang, HC; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2006)
"Monitoring acetic acid distribution on CT fluoroscopy can detect extratumoral diffusion and may optimize the distribution of acetic acid in hepatocellular carcinoma."3.72Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003)
"Percutaneous injection therapy using acetic acid or pure ethanol is effective for hepatocellular carcinoma (HCC)."3.72Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiency. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2004)
"Ultrasound (US)-guided percutaneous acetic acid injection therapy (PAIT) is effective for patients with hepatocellular carcinoma (HCC)."3.72Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2004)
"The purpose of our study is to evaluate the distribution of acetic acid mixed with iodinated contrast agent during percutaneous acetic acid injection on CT fluoroscopy for hepatocellular carcinoma."3.72Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003)
"To evaluate the safety and efficacy of single high-dose percutaneous acetic acid injection (PAI) for treatment of small (<3-cm-diameter) hepatocellular carcinoma (HCC)."3.70Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. ( Chen, CK; Cheng, JS; Lai, KH; Lai, PH; Liang, HL; Lo, GH; Pan, HB; Yang, CF, 2000)
"To compare the efficacy of ultrasound-guided percutaneous acetic acid injection and segmental transcatheter arterial embolization for hypervascular small hepatocellular carcinoma."3.69Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996)
"The prognosis of 40 patients with one to three angiographically hypervascular hepatocellular carcinoma smaller than 3 cm in diameter treated with either percutaneous acetic acid injection (25 patients) or transcatheter arterial embolization (15 patients) during the past 4."3.69Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996)
"Percutaneous acetic acid injection is superior to segmental transcatheter arterial embolization in the treatment of hypervascular small hepatocellular carcinoma."3.69Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996)
"One hundred and two patients with hepatocellular carcinoma were evaluated for treatment between 1999 and 2000."2.71Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005)
"The 1-, 2- and 3-year recurrence rate from the original main tumor was 0%, 20%, and 20%, respectively, in patients treated with percutaneous acetic acid injection alone and 12%, 24%, and 24% in patients treated with percutaneous acetic acid injection after transcatheter arterial embolization (P = NS)."2.68Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1996)
"Hepatocellular carcinoma is the fifth most common cancer worldwide."2.49Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. ( Franke, A; Jakobsen, JC; Mössner, J; Schoppmeyer, K; Weis, S, 2013)
"Hepatocellular carcinoma is in 90% of cases associated with cirrhosis and to preserve liver function while destroying the tumor is a main issue in these patients justifying the development of local percutaneous ablative therapies."2.44Transcutaneous treatments of hepatocellular carcinoma in patients with cirrhosis: present status and future developments. ( Beaugrand, M; Seror, O, 2007)
"Worldwide, hepatocellular carcinoma (HCC) is a common, refractory, malignant tumor."2.43Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives. ( Huang, YH; Huo, TI; Wu, JC, 2005)
"Keywords were Hepatocellular carcinoma, liver metastases, percutaneous ethanol injection, cryotherapy, microwave coagulation therapy, radiofrequency ablation, interstitial laser photocoagulation, focused high-intensity ultrasound, hot saline injection, electrolysis and acetic acid injection."2.42The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. ( Aylott, C; Berry, DP; Garcea, G; Lloyd, TD; Maddern, G, 2003)
"The H22 mouse hepatoma ascites model was replicated, and were given 3-O-EZ and ingenol seven days (110."1.62The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC. ( Chen, PD; Ju, YH; Tang, YP; Wang, K; Wu, JH; Yao, WF; Zhang, L; Zhang, M; Zhang, Q; Zhang, Y, 2021)
"Despite the increasing incidence of hepatocellular carcinoma (HCC) worldwide, current pharmacological treatments are still unsatisfactory."1.62Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth. ( Altomare, A; Cavalluzzi, MM; Gnocchi, D; Lentini, G; Mangiatordi, GF; Mazzocca, A; Rizzi, R; Sabbà, C; Spennacchio, M; Tortorella, C, 2021)
"Among patients with treatment delay, disease progression was registered in 30 (63%) patients."1.34Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias? ( Chi, CW; Chiang, JH; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2007)
"Thirty patients with 38 lesions of liver cancer were treated by the CT mediated intratumor injection of HAS6."1.33Destructive effect of percutaneous hydrochloric acid injection therapy for liver cancer--a preliminary experimental and clinical study. ( Hongmei, Z; Lei, Z; Ni, J; Suhong, H; Weijian, F; Yanjie, Z; Yi, C; Zan, L, 2006)
"The risk of disease progression in HCC patients stratified by tumor stage was mapped and equated with the risk of mortality of 456 cirrhotic patients without HCC."1.32Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy. ( Chang, FY; Hou, MC; Huang, YH; Huo, TI; Lee, FY; Lee, PC; Lee, SD; Lin, HC; Wu, JC, 2004)
"Hepatic resection for huge hepatocellular carcinoma (HCC) is challenging."1.32Multimodality management of hepatocellular carcinoma larger than 10 cm. ( Chen, IS; Chen, YC; Chou, NH; Liang, HL; Liu, SI; Lo, GH; Mok, KT; Tsai, CC; Wang, BW; Yeh, MH, 2003)
"Preliminary study in a patient with hepatoma revealed focal signal at the injection site."1.31Chemical-shift MR imaging of acetic acid during percutaneous chemical ablation therapy: preliminary work. ( Clark, TW; Leigh, JS; Mondschein, J; Roberts, DA; Rosen, MA; Siegelman, E; Soulen, MC, 2002)
"Single high-dose PAI is safe and effective for treatment of small HCC."1.31Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. ( Chen, CK; Cheng, JS; Lai, KH; Lai, PH; Liang, HL; Lo, GH; Pan, HB; Yang, CF, 2000)
"Two cases of liver metastasis from colon cancer were treated by percutaneous ethanol (PEI) and acetic acid (PAI) injection for the recurrent lesion after surgery."1.30[Percutaneous ethanol and acetic acid injection for liver metastasis from colon cancer--two case reports]. ( Iguchi, Y; Sato, K; Shibata, N; Takesue, M; Tsunoda, T; Yamamoto, S, 1998)
"The human hepatoma cell line Hep G2 can be maintained in continuous culture and secretes numerous plasma proteins and lipoproteins into the medium."1.27Regulation of low-density lipoprotein receptors in the human hepatoma cell line Hep G2. ( Hagemenas, FC; Illingworth, DD; Lindsey, S, 1984)
"A 24h pretreatment of the human hepatoma cell line HepG2 with dibutyryl cyclic AMP in the presence of theophylline induced a dose dependent decrease in low density lipoprotein binding, uptake and degradation."1.27Cyclic AMP decreases LDL catabolism and cholesterol synthesis in the human hepatoma cell line HepG2. ( Auclair, M; Maziere, C; Maziere, JC; Mora, L; Moreau, M; Polonovski, J; Salmon, S, 1988)

Research

Studies (72)

TimeframeStudies, this research(%)All Research%
pre-19904 (5.56)18.7374
1990's13 (18.06)18.2507
2000's39 (54.17)29.6817
2010's11 (15.28)24.3611
2020's5 (6.94)2.80

Authors

AuthorsStudies
Hou, J1
Chang, YJ2
Chen, LJ1
Chen, PD2
Zhang, Q1
Ju, YH1
Zhang, Y1
Wang, K1
Zhang, M1
Yao, WF1
Tang, YP1
Wu, JH1
Zhang, L1
Gnocchi, D1
Cavalluzzi, MM1
Mangiatordi, GF1
Rizzi, R1
Tortorella, C1
Spennacchio, M1
Lentini, G1
Altomare, A1
Sabbà, C1
Mazzocca, A1
Paul, SB1
Acharya, SK1
Gamanagatti, SR1
Sreenivas, V1
Shalimar, S1
Gulati, MS1
Weis, S3
Franke, A2
Mössner, J3
Jakobsen, JC1
Schoppmeyer, K3
Berg, T1
Fleig, WE2
Gonella, S1
Gonella, F1
Kang, JH1
Bruera, E1
Cabral de Melo, FC1
Borsato, D1
de Macedo Júnior, FC1
Mantovani, MS1
Luiz, RC1
Colabone-Celligoi, MA1
Tsai, WL1
Cheng, JS2
Lai, KH2
Lin, CP1
Lo, GH3
Hsu, PI1
Yu, HC1
Lin, CK1
Chan, HH1
Chen, WC1
Chen, TA1
Li, WL1
Liang, HL3
Kondo, T1
Kishi, M1
Fushimi, T1
Kaga, T1
Kolligs, FT1
Hoffmann, RT1
op den Winkel, M1
Bruns, CJ1
Herrmann, K1
Jakobs, TF1
Lamerz, R1
Trumm, C1
Zech, CJ1
Wilkowski, R1
Graeb, C1
Forner, A1
Bruix, J1
Germani, G1
Pleguezuelo, M1
Gurusamy, K1
Meyer, T1
Isgrò, G1
Burroughs, AK1
Huo, TI10
Hsu, CY1
Huang, YH11
Su, CW1
Lin, HC2
Lee, RC1
Chiou, YY1
Chiang, JH4
Lee, PC10
Lee, SD10
Ma, H1
Liu, J1
Liu, F1
Islam, MN1
Azad, SA1
Karim, E1
Rahman, SM1
Khan, NA1
Roberts, DA1
Rosen, MA1
Clark, TW2
Mondschein, J1
Soulen, MC1
Siegelman, E1
Leigh, JS1
Arrivé, L2
Rosmorduc, O2
Dahan, H1
Fartoux, L2
Monnier-Cholley, L1
Lewin, M1
Poupon, R2
Tubiana, JM2
Lau, WY2
Leung, TW1
Yu, SC1
Ho, SK1
Wu, JC10
Chang, FY8
Lin, SM3
Lin, DY1
Ke, WZ1
Yu, DW1
Gu, BP1
Zhuang, ZW1
MORI, K1
EMMELOT, P1
VAN VALS, GH1
Garcea, G1
Lloyd, TD1
Aylott, C1
Maddern, G1
Berry, DP1
Mok, KT1
Wang, BW1
Liu, SI1
Chou, NH1
Tsai, CC1
Chen, IS1
Yeh, MH1
Chen, YC2
Zuber-Jerger, I1
Geissler, M1
Spangenberg, HC1
Mohr, L1
Weizsäcker, F1
Blum, HE1
Huo, T1
Lee, FY1
Hou, MC1
Park, JH1
Oh, JH1
Yoon, Y1
Hong, SH1
Park, SJ1
Lin, CJ1
Lin, CC1
Hsu, CW1
Andreani, T1
Serfaty, L1
Chazouillères, O1
Arienti, V1
Pretolani, S1
Huang, HC1
Lencioni, R1
Della Pina, C1
Crocetti, L1
Cioni, D1
Guan, YS1
Liu, Y1
Weijian, F1
Zan, L1
Suhong, H1
Hongmei, Z1
Lei, Z1
Yanjie, Z1
Yi, C1
Ni, J1
Chi, CW1
Ho, CL1
Chen, S1
Yeung, DW1
Cheng, TK1
Garrean, S1
Hering, J1
Helton, WS1
Espat, NJ1
Beaugrand, M1
Seror, O1
Seki, T1
Morimura, S1
Tabata, S1
Tang, Y1
Shigematsu, T1
Kida, K1
Illingworth, DD1
Lindsey, S1
Hagemenas, FC1
Ohnishi, K7
Ohyama, N1
Ito, S5
Fujiwara, K5
Parker, RA1
Pearce, BC1
Clark, RW1
Gordon, DA1
Wright, JJ1
Gebhardt, R1
Nomura, F1
Yoshioka, H3
Kosaka, K1
Toshima, K1
Nishiyama, J1
Kameda, C1
Peluso, MR1
Dixon, JL1
Fan, ST1
Yamamoto, S1
Iguchi, Y1
Shibata, N1
Takesue, M1
Tsunoda, T1
Sato, K1
Hou, C1
Chen, SC1
Chang, WY1
Chen, CH1
Okada, S1
Yang, CF1
Pan, HB1
Chen, CK1
Lai, PH1
Hargreaves, GM1
Adam, R1
Bismuth, H1
Georgiades, CS1
Ramsey, DE1
Solomon, S1
Geschwind, JF1
Chao, A1
Lai, CH1
Hsueh, S1
Chang, TC1
Maziere, C1
Maziere, JC1
Salmon, S1
Auclair, M1
Mora, L1
Moreau, M1
Polonovski, J1

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Radiofrequency Ablation Versus Laser Ablation for the Treatment of Small Hepatocellular Carcinoma: a Randomized Controlled Trial[NCT01096914]140 participants (Actual)Interventional2009-01-31Completed
Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Small Hepatocellular Carcinoma:A Phase III, Prospective, Randomized, Open, Parallel Controlled Clinical Trial[NCT03898921]Phase 3270 participants (Anticipated)Interventional2019-03-10Recruiting
Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for the Treatment of Recurrent Small Hepatocellular Carcinoma: a Prospective, Open, Randomized, Controlled Clinical Study[NCT04047173]166 participants (Anticipated)Interventional2019-08-12Recruiting
A Phase I-II Study to Evaluate, in Patients Operated for a Hepatic Resection of Colorectal Liver Metastases, a High Intensity Focused Ultrasound (HIFU) Procedure: Feasibility, Safety and Accuracy.[NCT01489787]38 participants (Anticipated)Interventional2010-03-31Recruiting
Feasibility of 11C-acetate in the Monitoring of Treatment Response Following Radiotherapy in Patients With Hepatocellular Carcinoma[NCT02549755]Phase 21 participants (Actual)Interventional2015-09-30Terminated (stopped due to Poor enrollment)
"A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SUPPLEMENTATION WITH KIOLIC® IN PATIENTS WITH DIAGNOSIS OF METABOLIC SYNDROME TO IMPROVE ENDOTHELIAL FUNCTION AND INFLAMMATORY STATE. KYMES"[NCT01168700]Phase 446 participants (Anticipated)Interventional2009-11-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

20 reviews available for acetic acid and Liver Neoplasms

ArticleYear
Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
    The Cochrane database of systematic reviews, 2013, Dec-19, Issue:12

    Topics: Acetic Acid; Administration, Cutaneous; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Hepat

2013
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    The Cochrane database of systematic reviews, 2015, Jan-26, Volume: 1

    Topics: Acetic Acid; Administration, Cutaneous; Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Cat

2015
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3

    Topics: Acetic Acid; Administration, Cutaneous; Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Cat

2009
[Diagnosis and multimodal therapy for hepatocellular carcinoma].
    Zeitschrift fur Gastroenterologie, 2010, Volume: 48, Issue:2

    Topics: Acetic Acid; Antineoplastic Agents; Brachytherapy; Carcinoma, Hepatocellular; Catheter Ablation; Che

2010
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
    Journal of hepatology, 2010, Volume: 52, Issue:3

    Topics: Acetic Acid; Administration, Cutaneous; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Human

2010
Interventional radiology for the treatment of hepatic malignancy.
    Mymensingh medical journal : MMJ, 2012, Volume: 21, Issue:2

    Topics: Acetic Acid; Brachytherapy; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality The

2012
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
    Annals of surgery, 2003, Volume: 237, Issue:2

    Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Contraindications;

2003
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
    Annals of surgery, 2003, Volume: 237, Issue:2

    Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Contraindications;

2003
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
    Annals of surgery, 2003, Volume: 237, Issue:2

    Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Contraindications;

2003
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
    Annals of surgery, 2003, Volume: 237, Issue:2

    Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Contraindications;

2003
Percutaneous local ablation therapy in small hepatocellular carcinoma.
    Chang Gung medical journal, 2003, Volume: 26, Issue:5

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Electrocoagulation; Ethanol; Humans; Inje

2003
The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:15

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Cryotherapy; Electrolysis; Ethanol; Human

2003
[Local ablation of malignant lesions of the liver - potential applications and limitations of the different methods].
    Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:1

    Topics: Acetic Acid; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Catheter Abla

2004
Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives.
    Journal of the Chinese Medical Association : JCMA, 2005, Volume: 68, Issue:4

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Indicators and Reagents;

2005
Percutaneous ablation of hepatocellular carcinoma.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2006, Volume: 167

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Clinical Trials as Topic; Ethanol; Humans

2006
Interventional treatments for hepatocellular carcinoma.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2006, Volume: 5, Issue:4

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Cryosurge

2006
A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors.
    American journal of surgery, 2007, Volume: 194, Issue:1

    Topics: Acetic Acid; Antineoplastic Agents; Catheter Ablation; Cryosurgery; Embolization, Therapeutic; Ethan

2007
Chemical ablation of liver cancer.
    Techniques in vascular and interventional radiology, 2007, Volume: 10, Issue:1

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Injections, Intralesiona

2007
Transcutaneous treatments of hepatocellular carcinoma in patients with cirrhosis: present status and future developments.
    Current pharmaceutical design, 2007, Volume: 13, Issue:32

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Combined Modality Therapy; Ethanol; Human

2007
Local ablation therapy for hepatocellular carcinoma.
    Seminars in liver disease, 1999, Volume: 19, Issue:3

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Injections, Intralesiona

1999
Results after nonsurgical local treatment of primary liver malignancies.
    Langenbeck's archives of surgery, 2000, Volume: 385, Issue:3

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Cryosurgery; Embolization, Therapeutic; Ethanol; Humans; Hyp

2000
New nonsurgical therapies in the treatment of hepatocellular carcinoma.
    Techniques in vascular and interventional radiology, 2001, Volume: 4, Issue:3

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Infusions, Intra-Arteria

2001
[Percutaneous acetic acid injection therapy].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 6

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Clinical Trials as Topic; Combined Modali

2001

Trials

12 trials available for acetic acid and Liver Neoplasms

ArticleYear
Acetic acid versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A randomized controlled trial.
    Diagnostic and interventional imaging, 2020, Volume: 101, Issue:2

    Topics: Acetic Acid; Adult; Aged; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle A

2020
Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.
    Scandinavian journal of gastroenterology, 2003, Volume: 38, Issue:7

    Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug

2003
Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:11

    Topics: Acetic Acid; Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chem

2003
Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:5

    Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeut

2004
Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
    Alimentary pharmacology & therapeutics, 2004, Jun-15, Volume: 19, Issue:12

    Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemo

2004
Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.
    Gut, 2005, Volume: 54, Issue:8

    Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Female; H

2005
Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection.
    Gastroenterologie clinique et biologique, 2005, Volume: 29, Issue:12

    Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Feasi

2005
Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid.
    Radiology, 1994, Volume: 193, Issue:3

    Topics: Acetates; Acetic Acid; Aged; Animals; Biopsy, Needle; Carcinoma, Hepatocellular; Chemoembolization,

1994
Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases.
    Hepatology (Baltimore, Md.), 1996, Volume: 23, Issue:5

    Topics: Acetates; Acetic Acid; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Bi

1996
Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection.
    Hepatology (Baltimore, Md.), 1996, Volume: 24, Issue:6

    Topics: Acetic Acid; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Follow-Up Studies;

1996
Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Hepatology (Baltimore, Md.), 1998, Volume: 27, Issue:1

    Topics: Acetic Acid; Administration, Cutaneous; Aged; Carcinoma, Hepatocellular; Ethanol; Female; Humans; In

1998
Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Hepato-gastroenterology, 1998, Volume: 45 Suppl 3

    Topics: Acetic Acid; Administration, Cutaneous; Aged; Carcinoma, Hepatocellular; Ethanol; Female; Humans; In

1998

Other Studies

40 other studies available for acetic acid and Liver Neoplasms

ArticleYear
Drinking vinegar, a potential adjuvant for immunotherapy of HCC?
    Hepatology (Baltimore, Md.), 2023, 01-01, Volume: 77, Issue:1

    Topics: Acetic Acid; Adjuvants, Immunologic; Carcinoma, Hepatocellular; Humans; Immunotherapy; Liver Neoplas

2023
Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2020, Volume: 46, Issue:9

    Topics: Ablation Techniques; Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease

2020
The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC.
    Journal of ethnopharmacology, 2021, Mar-01, Volume: 267

    Topics: Acetic Acid; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Aquaporin 2; Aquaporins; Ascites

2021
Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth.
    ChemMedChem, 2021, 07-06, Volume: 16, Issue:13

    Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Dose-

2021
Use of vinegar to relieve persistent hiccups in an advanced cancer patient.
    Journal of palliative medicine, 2015, Volume: 18, Issue:5

    Topics: Acetic Acid; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Hiccup

2015
Hiccups during Chemotherapy: What Should We Do?
    Journal of palliative medicine, 2015, Volume: 18, Issue:7

    Topics: Acetic Acid; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Hiccup; Humans; Live

2015
Study of levan productivity from Bacillus subtilis Natto by surface response methodology and its antitumor activity against HepG2 cells using metabolomic approach.
    Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:6

    Topics: Acetic Acid; Alanine; Antineoplastic Agents; Bacillus subtilis; Energy Metabolism; Fermentation; Fru

2015
Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study.
    Alimentary pharmacology & therapeutics, 2008, Aug-01, Volume: 28, Issue:3

    Topics: Acetic Acid; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Ethano

2008
Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation.
    Journal of agricultural and food chemistry, 2009, Jul-08, Volume: 57, Issue:13

    Topics: Acetic Acid; Acetyl-CoA Carboxylase; Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Fa

2009
Ablation for hepatocellular carcinoma: Is there need to have a winning technique?
    Journal of hepatology, 2010, Volume: 52, Issue:3

    Topics: Acetic Acid; Administration, Cutaneous; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Human

2010
Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy.
    BMC gastroenterology, 2010, Dec-31, Volume: 10

    Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; Catheter

2010
CT-guided single high-dose percutaneous acetic acid injection for small hepatocellular carcinoma: a long-term follow-up study.
    European journal of radiology, 2012, Volume: 81, Issue:6

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Humans; Inje

2012
Chemical-shift MR imaging of acetic acid during percutaneous chemical ablation therapy: preliminary work.
    Journal of vascular and interventional radiology : JVIR, 2002, Volume: 13, Issue:10

    Topics: Acetic Acid; Animals; Carcinoma, Hepatocellular; Cattle; Contrast Media; Gadolinium; Humans; Injecti

2002
Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent.
    AJR. American journal of roentgenology, 2003, Volume: 180, Issue:1

    Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Fluo

2003
[Raman spectroscopic study of microscopic damage on the space structure of DNA with acetic acid].
    Guang pu xue yu guang pu fen xi = Guang pu, 2001, Volume: 21, Issue:6

    Topics: Acetic Acid; Animals; Chemoembolization, Therapeutic; DNA Damage; Fishes; Humans; Liver Neoplasms; N

2001
Inhibition of experimental production of liver cancer by addition of acetic acid to the diet.
    Gan, 1953, Volume: 44, Issue:4

    Topics: Acetates; Acetic Acid; Animals; Bile Duct Neoplasms; Carcinogens; Diet; Liver Neoplasms; Neoplasms,

1953
The metabolism of neoplastic tissues; the metabolic activity of normal and cancerous rat livers studied with acetate-1-14C invitro.
    Zeitschrift fur Krebsforschung, 1957, Volume: 62, Issue:2

    Topics: Acetates; Acetic Acid; Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Liver Neoplasms; Rats

1957
Multimodality management of hepatocellular carcinoma larger than 10 cm.
    Journal of the American College of Surgeons, 2003, Volume: 197, Issue:5

    Topics: Acetic Acid; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Pr

2003
Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection.
    Scandinavian journal of gastroenterology, 2004, Volume: 39, Issue:2

    Topics: Acetic Acid; Administration, Cutaneous; Aged; Carcinoma, Hepatocellular; Female; Humans; Injections,

2004
Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiency.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:3

    Topics: Acetic Acid; Aged; Antineoplastic Agents; Ascites; Carcinoma, Hepatocellular; Creatinine; Ethanol; F

2004
Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:12

    Topics: Acetic Acid; Administration, Cutaneous; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeu

2004
Acetic acid sclerotherapy for treatment of a biliary leak from an isolated bile duct after hepatic surgery.
    Journal of vascular and interventional radiology : JVIR, 2005, Volume: 16, Issue:6

    Topics: Acetic Acid; Bile Duct Diseases; Bile Ducts; Cystadenocarcinoma; Female; Hepatectomy; Humans; Liver

2005
Complication rates of ablation therapies for hepatocellular carcinoma: a difficult comparison with an easy solution.
    Gut, 2006, Volume: 55, Issue:8

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Injections, Intralesiona

2006
Fever and infectious complications after percutaneous acetic acid injection therapy for hepatocellular carcinoma: incidence and risk factor analysis.
    Journal of clinical gastroenterology, 2006, Volume: 40, Issue:7

    Topics: Abscess; Acetic Acid; Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Carcinoma, Hepatocellu

2006
Destructive effect of percutaneous hydrochloric acid injection therapy for liver cancer--a preliminary experimental and clinical study.
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:12

    Topics: Acetic Acid; Animals; Cell Line, Tumor; Ethanol; Gastric Juice; Humans; Hydrochloric Acid; In Vitro

2006
Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?
    Scandinavian journal of gastroenterology, 2007, Volume: 42, Issue:4

    Topics: Acetic Acid; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; E

2007
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:6

    Topics: Acetic Acid; Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carci

2007
Antioxidant activity of vinegar produced from distilled residues of the Japanese liquor shochu.
    Journal of agricultural and food chemistry, 2008, May-28, Volume: 56, Issue:10

    Topics: Acetic Acid; Alcoholic Beverages; Animals; Antioxidants; Carbon Tetrachloride; Carcinoma, Hepatocell

2008
Regulation of low-density lipoprotein receptors in the human hepatoma cell line Hep G2.
    Experimental cell research, 1984, Volume: 155, Issue:2

    Topics: Acetates; Acetic Acid; Carcinoma, Hepatocellular; Cell Line; Cholesterol; Humans; Kinetics; Lipoprot

1984
Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    The Journal of biological chemistry, 1993, May-25, Volume: 268, Issue:15

    Topics: Acetates; Acetic Acid; Androstenes; Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell L

1993
Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes.
    Lipids, 1993, Volume: 28, Issue:7

    Topics: Acetates; Acetic Acid; Animals; Anticholesteremic Agents; Carcinoma, Hepatocellular; Cells, Cultured

1993
Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:12

    Topics: Acetic Acid; Aged; Angiography; Arteries; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fema

1996
Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.
    Lipids, 1997, Volume: 32, Issue:8

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Acetic Acid; Apolipoprotein B-100; Apolipoproteins B; beta-Cyclod

1997
Can small hepatocellular carcinoma be cured by percutaneous acetic acid injection therapy?
    HPB surgery : a world journal of hepatic, pancreatic and biliary surgery, 1997, Volume: 10, Issue:5

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Humans; Injections, Intralesional; Liver Neoplasms; Ultrason

1997
[Percutaneous ethanol and acetic acid injection for liver metastasis from colon cancer--two case reports].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:5

    Topics: Acetic Acid; Carcinoembryonic Antigen; Colon, Sigmoid; Colonic Neoplasms; Ethanol; Female; Hepatecto

1998
Comparison of necrotic characteristics and benefits between 50% acetic acid and pure ethanol in local hepatic injection: a study in rats.
    The Kaohsiung journal of medical sciences, 1999, Volume: 15, Issue:7

    Topics: Acetic Acid; Animals; Ethanol; Liver; Liver Neoplasms; Male; Necrosis; Rats; Rats, Sprague-Dawley

1999
Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment.
    Radiology, 2000, Volume: 214, Issue:3

    Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Dose-Response Relationship,

2000
Local ablative therapy for hepatocellular carcinoma.
    Endoscopy, 2000, Volume: 32, Issue:8

    Topics: Acetic Acid; Carcinoma, Hepatocellular; Ethanol; Humans; Hyperthermia, Induced; Injections, Intrales

2000
Intralesional injection for hepatic metastasis from cervical carcinoma. A report of two cases.
    The Journal of reproductive medicine, 2001, Volume: 46, Issue:11

    Topics: Acetic Acid; Aged; Carcinoma; Ethanol; Female; Humans; Indicators and Reagents; Injections, Intrales

2001
Cyclic AMP decreases LDL catabolism and cholesterol synthesis in the human hepatoma cell line HepG2.
    Biochemical and biophysical research communications, 1988, Oct-14, Volume: 156, Issue:1

    Topics: Acetates; Acetic Acid; Bucladesine; Carcinoma, Hepatocellular; Cell Line; Cholesterol; Cyclic AMP; H

1988